Norges Bank’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,700
Closed -$234K 542
2024
Q4
$234K Buy
+40,700
New +$234K ﹤0.01% 1823
2024
Q3
Sell
-40,700
Closed -$528K 555
2024
Q2
$528K Buy
+40,700
New +$528K ﹤0.01% 1874
2023
Q3
Sell
-150,614
Closed -$3.22M 1990
2023
Q2
$3.22M Buy
150,614
+28,000
+23% +$599K ﹤0.01% 1809
2023
Q1
$4.96M Sell
122,614
-103,805
-46% -$4.2M ﹤0.01% 1760
2022
Q4
$10.5M Buy
226,419
+66,600
+42% +$3.1M ﹤0.01% 1553
2022
Q3
$8.29M Buy
159,819
+20,313
+15% +$1.05M ﹤0.01% 1599
2022
Q2
$6.59M Hold
139,506
﹤0.01% 1697
2022
Q1
$9.93M Buy
139,506
+15,162
+12% +$1.08M ﹤0.01% 1703
2021
Q4
$9.3M Buy
124,344
+14,408
+13% +$1.08M ﹤0.01% 1785
2021
Q3
$6.25M Hold
109,936
﹤0.01% 1891
2021
Q2
$4.84M Sell
109,936
-18,978
-15% -$835K ﹤0.01% 1914
2021
Q1
$6.36M Sell
128,914
-25,088
-16% -$1.24M ﹤0.01% 1880
2020
Q4
$6.48M Sell
154,002
-5,692
-4% -$240K ﹤0.01% 1843
2020
Q3
$7.31M Sell
159,694
-5,391
-3% -$247K ﹤0.01% 1800
2020
Q2
$8.29M Sell
165,085
-46,047
-22% -$2.31M ﹤0.01% 1768
2020
Q1
$10.9M Hold
211,132
﹤0.01% 1575
2019
Q4
$13M Hold
211,132
﹤0.01% 1719
2019
Q3
$12.7M Buy
211,132
+11,986
+6% +$720K ﹤0.01% 1694
2019
Q2
$16.8M Buy
199,146
+10,845
+6% +$915K 0.01% 1597
2019
Q1
$18M Buy
188,301
+87,975
+88% +$8.4M 0.01% 1564
2018
Q4
$7.11M Buy
100,326
+13,078
+15% +$926K ﹤0.01% 1845
2018
Q3
$7.46M Buy
+87,248
New +$7.46M ﹤0.01% 1897